1
|
Capsaicin and TRPV1 Channels in the Cardiovascular System: The Role of Inflammation. Cells 2021; 11:cells11010018. [PMID: 35011580 PMCID: PMC8750852 DOI: 10.3390/cells11010018] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2021] [Revised: 12/17/2021] [Accepted: 12/20/2021] [Indexed: 12/24/2022] Open
Abstract
Capsaicin is a potent agonist of the Transient Receptor Potential Vanilloid type 1 (TRPV1) channel and is a common component found in the fruits of the genus Capsicum plants, which have been known to humanity and consumed in food for approximately 7000-9000 years. The fruits of Capsicum plants, such as chili pepper, have been long recognized for their high nutritional value. Additionally, capsaicin itself has been proposed to exhibit vasodilatory, antimicrobial, anti-cancer, and antinociceptive properties. However, a growing body of evidence reveals a vasoconstrictory potential of capsaicin acting via the vascular TRPV1 channel and suggests that unnecessary high consumption of capsaicin may cause severe consequences, including vasospasm and myocardial infarction in people with underlying inflammatory conditions. This review focuses on vascular TRPV1 channels that are endogenously expressed in both vascular smooth muscle and endothelial cells and emphasizes the role of inflammation in sensitizing the TRPV1 channel to capsaicin activation. Tilting the balance between the beneficial vasodilatory action of capsaicin and its unwanted vasoconstrictive effects may precipitate adverse outcomes such as vasospasm and myocardial infarction, especially in the presence of proinflammatory mediators.
Collapse
|
2
|
Ryu V, Watts AG, Xue B, Bartness TJ. Bidirectional crosstalk between the sensory and sympathetic motor systems innervating brown and white adipose tissue in male Siberian hamsters. Am J Physiol Regul Integr Comp Physiol 2017; 312:R324-R337. [PMID: 28077392 DOI: 10.1152/ajpregu.00456.2015] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2015] [Revised: 11/28/2016] [Accepted: 12/31/2016] [Indexed: 01/31/2023]
Abstract
The brain networks connected to the sympathetic motor and sensory innervations of brown (BAT) and white (WAT) adipose tissues were originally described using two transneuronally transported viruses: the retrogradely transported pseudorabies virus (PRV), and the anterogradely transported H129 strain of herpes simplex virus-1 (HSV-1 H129). Further complexity was added to this network organization when combined injections of PRV and HSV-1 H129 into either BAT or WAT of the same animal generated sets of coinfected neurons in the brain, spinal cord, and sympathetic and dorsal root ganglia. These neurons are well positioned to act as sensorimotor links in the feedback circuits that control each fat pad. We have now determined the extent of sensorimotor crosstalk between interscapular BAT (IBAT) and inguinal WAT (IWAT). PRV152 and HSV-1 H129 were each injected into IBAT or IWAT of the same animal: H129 into IBAT and PRV152 into IWAT. The reverse configuration was applied in a different set of animals. We found single-labeled neurons together with H129+PRV152 coinfected neurons in multiple brain sites, with lesser numbers in the sympathetic and dorsal root ganglia that innervate IBAT and IWAT. We propose that these coinfected neurons mediate sensory-sympathetic motor crosstalk between IBAT and IWAT. Comparing the relative numbers of coinfected neurons between the two injection configurations showed a bias toward IBAT-sensory and IWAT-sympathetic motor feedback loops. These coinfected neurons provide a neuroanatomical framework for functional interactions between IBAT thermogenesis and IWAT lipolysis that occurs with cold exposure, food restriction/deprivation, exercise, and more generally with alterations in adiposity.
Collapse
Affiliation(s)
- Vitaly Ryu
- Department of Biology, Obesity Reversal Center, Georgia State University, Atlanta, Georgia; and
| | - Alan G Watts
- Department of Biological Sciences, University of Southern California, Dornsife College of Letters, Arts, and Sciences, University of Southern California, Los Angeles, California
| | - Bingzhong Xue
- Department of Biology, Obesity Reversal Center, Georgia State University, Atlanta, Georgia; and
| | - Timothy J Bartness
- Department of Biology, Obesity Reversal Center, Georgia State University, Atlanta, Georgia; and
| |
Collapse
|
3
|
TRP Channels as Therapeutic Targets in Diabetes and Obesity. Pharmaceuticals (Basel) 2016; 9:ph9030050. [PMID: 27548188 PMCID: PMC5039503 DOI: 10.3390/ph9030050] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2016] [Revised: 08/10/2016] [Accepted: 08/11/2016] [Indexed: 12/16/2022] Open
Abstract
During the last three to four decades the prevalence of obesity and diabetes mellitus has greatly increased worldwide, including in the United States. Both the short- and long-term forecasts predict serious consequences for the near future, and encourage the development of solutions for the prevention and management of obesity and diabetes mellitus. Transient receptor potential (TRP) channels were identified in tissues and organs important for the control of whole body metabolism. A variety of TRP channels has been shown to play a role in the regulation of hormone release, energy expenditure, pancreatic function, and neurotransmitter release in control, obese and/or diabetic conditions. Moreover, dietary supplementation of natural ligands of TRP channels has been shown to have potential beneficial effects in obese and diabetic conditions. These findings raised the interest and likelihood for potential drug development. In this mini-review, we discuss possibilities for better management of obesity and diabetes mellitus based on TRP-dependent mechanisms.
Collapse
|
4
|
Lipolysis sensation by white fat afferent nerves triggers brown fat thermogenesis. Mol Metab 2016; 5:626-634. [PMID: 27656400 PMCID: PMC5021673 DOI: 10.1016/j.molmet.2016.06.013] [Citation(s) in RCA: 56] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/07/2016] [Revised: 06/24/2016] [Accepted: 06/26/2016] [Indexed: 01/31/2023] Open
Abstract
Objective Metabolic challenges, such as a cold environment, stimulate sympathetic neural efferent activity to white adipose tissue (WAT) to drive lipolysis, thereby increasing the availability of free fatty acids as one source of fuel for brown adipose tissue (BAT) thermogenesis. WAT is also innervated by sensory nerve fibers that network to metabolic brain areas; moreover, activation of these afferents is reported to increase sympathetic nervous system outflow. However, the endogenous stimuli sufficient to drive WAT afferents during metabolic challenges as well as their functional relation to BAT thermogenesis remain unknown. Method We tested if local WAT lipolysis directly activates WAT afferent nerves, and then assessed whether this WAT sensory signal affected BAT thermogenesis in Siberian hamsters (Phodopus sungorus). Results 2-deoxyglucose, a sympathetic nervous system stimulant, caused β-adrenergic receptor dependent increases in inguinal WAT (IWAT) afferent neurophysiological activity. In addition, direct IWAT injections of the β3-AR agonist CL316,243 dose-dependently increased: 1) phosphorylation of IWAT hormone sensitive lipase, an indicator of SNS-stimulated lipolysis, 2) expression of the neuronal activation marker c-Fos in dorsal root ganglion neurons receiving sensory input from IWAT, and 3) IWAT afferent neurophysiological activity, an increase blocked by antilipolytic agent 3,5-dimethylpyrazole. Finally, we demonstrated that IWAT afferent activation by lipolysis triggers interscapular BAT thermogenesis through a neural link between these two tissues. Conclusions These data suggest IWAT lipolysis activates local IWAT afferents triggering a neural circuit from WAT to BAT that acutely induces BAT thermogenesis. Glucoprivation-induced lipolysis activates sensory nerves from white fat via β-adrenoreceptors. Lipolysis sensation by local afferent nerves innervating white fat is proposed. Lipid products of lipolysis are sufficient to activate sensory nerves from white fat. Stimulation of white fat afferents by lipolysis increases brown fat temperature. Findings illustrate functional neural connectivity between white and brown fat.
Collapse
|
5
|
Abstract
Fibromyalgia (FM) syndrome is characterized by widespread pain that is exacerbated by cold and stress but relieved by warmth. We review the points along thermal and pain pathways where temperature may influence pain. We also present evidence addressing the possibility that brown adipose tissue activity is linked to the pain of FM given that cold initiates thermogenesis in brown adipose tissue through adrenergic activity, whereas warmth suspends thermogenesis. Although females have a higher incidence of FM and more resting thermogenesis, they are less able to recruit brown adipose tissue in response to chronic stress than males. In addition, conditions that are frequently comorbid with FM compromise brown adipose activity making it less responsive to sympathetic stimulation. This results in lower body temperatures, lower metabolic rates, and lower circulating cortisol/corticosterone in response to stress--characteristics of FM. In the periphery, sympathetic nerves to brown adipose also project to surrounding tissues, including tender points characterizing FM. As a result, the musculoskeletal hyperalgesia associated with conditions such as FM may result from referred pain in the adjacent muscle and skin.
Collapse
|
6
|
Vaughan CH, Bartness TJ. Anterograde transneuronal viral tract tracing reveals central sensory circuits from brown fat and sensory denervation alters its thermogenic responses. Am J Physiol Regul Integr Comp Physiol 2012; 302:R1049-58. [PMID: 22378771 DOI: 10.1152/ajpregu.00640.2011] [Citation(s) in RCA: 76] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Brown adipose tissue (BAT) thermogenic activity and growth are controlled by its sympathetic nervous system (SNS) innervation, but nerve fibers containing sensory-associated neuropeptides [substance P, calcitonin gene-related peptide (CGRP)] also suggest sensory innervation. The central nervous system (CNS) projections of BAT afferents are unknown. Therefore, we used the H129 strain of the herpes simplex virus-1 (HSV-1), an anterograde transneuronal viral tract tracer used to delineate sensory nerve circuits, to define these projections. HSV-1 was injected into interscapular BAT (IBAT) of Siberian hamsters and HSV-1 immunoreactivity (ir) was assessed 24, 48, 72, 96, and 114 h postinjection. The 96- and 114-h groups had the most HSV-1-ir neurons with marked infections in the hypothalamic paraventricular nucleus, periaqueductal gray, olivary areas, parabrachial nuclei, raphe nuclei, and reticular areas. These sites also are involved in sympathetic outflow to BAT suggesting possible BAT sensory-SNS thermogenesis feedback circuits. We tested the functional contribution of IBAT sensory innervation on thermogenic responses to an acute (24 h) cold exposure test by injecting the specific sensory nerve toxin capsaicin directly into IBAT pads and then measuring core (T(c)) and IBAT (T(IBAT)) temperature responses. CGRP content was significantly decreased in capsaicin-treated IBAT demonstrating successful sensory nerve destruction. T(IBAT) and T(c) were significantly decreased in capsaicin-treated hamsters compared with the saline controls at 2 h of cold exposure. Thus the central sensory circuits from IBAT have been delineated for the first time, and impairment of sensory feedback from BAT appears necessary for the appropriate, initial thermogenic response to acute cold exposure.
Collapse
Affiliation(s)
- Cheryl H Vaughan
- Dept. of Biology, Georgia State Univ., Atlanta, GA 30302-4010, USA
| | | |
Collapse
|
7
|
Gross K, Karagiannides I, Thomou T, Koon HW, Bowe C, Kim H, Giorgadze N, Tchkonia T, Pirtskhalava T, Kirkland JL, Pothoulakis C. Substance P promotes expansion of human mesenteric preadipocytes through proliferative and antiapoptotic pathways. Am J Physiol Gastrointest Liver Physiol 2009; 296:G1012-9. [PMID: 19282377 PMCID: PMC2696212 DOI: 10.1152/ajpgi.90351.2008] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
White adipose tissue is intimately involved in the regulation of immunity and inflammation. We reported that human mesenteric preadipocytes express the substance P (SP)-mediated neurokinin-1 receptor (NK-1R), which signals proinflammatory responses. Here we tested the hypothesis that SP promotes proliferation and survival of human mesenteric preadipocytes and investigated responsible mechanism(s). Preadipocytes were isolated from mesenteric fat biopsies during gastric bypass surgery. Proliferative and antiapoptotic responses were delineated in 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS), bromodeoxyuridine (BrdU), caspase-3, and TUNEL assays, as well as Western immunoanalysis. SP (10(-7) M) increased MTS and proliferation (BrdU) and time dependently (15-30 min) induced Akt, EGF receptor, IGF receptor, integrin alphaVbeta3, phosphatidylinositol 3-kinase, and PKC-theta phosphorylation. Furthermore, pharmacological antagonism of Akt and PKC-theta activation significantly attenuated SP-induced preadipocyte proliferation. Exposure of preadipocytes to the proapoptotic Fas ligand (FasL, 100 microM) resulted in nuclear DNA fragmentation (TUNEL assay), as well as increased cleaved poly (ADP-ribose) polymerase, cleaved caspase-7, and caspase-3 expression. Cotreatment with SP almost completely abolished these responses in a NK-1R-dependent fashion. SP (10(-7) M) also time dependently stimulated expression 4E binding protein 1 and phosphorylation of p70 S6 kinase, which increased protein translation efficiency. SP increases preadipocyte viability, reduces apoptosis, and stimulates proliferation, possibly via cell cycle upregulation and increased protein translation efficiency. SP-induced proliferative and antiapoptotic pathways in fat depots may contribute to development of the creeping fat and inflammation characteristic of Crohn's disease.
Collapse
Affiliation(s)
- Kara Gross
- Gastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Inflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; Columbia University Medical Center, Department of Pediatrics, New York, New York; and Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota
| | - Iordanes Karagiannides
- Gastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Inflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; Columbia University Medical Center, Department of Pediatrics, New York, New York; and Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota
| | - Thomas Thomou
- Gastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Inflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; Columbia University Medical Center, Department of Pediatrics, New York, New York; and Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota
| | - Hon Wai Koon
- Gastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Inflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; Columbia University Medical Center, Department of Pediatrics, New York, New York; and Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota
| | - Collin Bowe
- Gastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Inflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; Columbia University Medical Center, Department of Pediatrics, New York, New York; and Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota
| | - Ho Kim
- Gastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Inflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; Columbia University Medical Center, Department of Pediatrics, New York, New York; and Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota
| | - Nino Giorgadze
- Gastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Inflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; Columbia University Medical Center, Department of Pediatrics, New York, New York; and Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota
| | - Tamara Tchkonia
- Gastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Inflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; Columbia University Medical Center, Department of Pediatrics, New York, New York; and Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota
| | - Tamara Pirtskhalava
- Gastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Inflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; Columbia University Medical Center, Department of Pediatrics, New York, New York; and Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota
| | - James L. Kirkland
- Gastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Inflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; Columbia University Medical Center, Department of Pediatrics, New York, New York; and Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota
| | - Charalabos Pothoulakis
- Gastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Inflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; Columbia University Medical Center, Department of Pediatrics, New York, New York; and Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota
| |
Collapse
|
8
|
Karagiannides I, Pothoulakis C. Neuropeptides, mesenteric fat, and intestinal inflammation. Ann N Y Acad Sci 2009; 1144:127-35. [PMID: 19076372 DOI: 10.1196/annals.1418.009] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
The ability of fat tissue cells to produce proinflammatory cytokines and the concept that obesity represents a low-grade inflammatory response have been well documented during the past decade. The effects of fat-mediated inflammation on metabolic pathologies have also been drawing increasing interest. However, very little is known on the potential effects of adipose tissue in the pathophysiology of gastrointestinal diseases with an inflammatory component, such as inflammatory bowel disease (IBD). The development of large fat masses around the inflamed intestine during Crohn's disease makes this tissue a candidate for more intense investigation in studies aiming to gain insights into the pathogenesis and progress of the disease. Furthermore, neuropeptides act in many cases in a proinflammatory manner and are shown to participate in the pathogenesis of intestinal inflammation in animal models of IBD. However, the potential of these molecules to interact with fat cells in the context of IBD has not been investigated. In this review the authors' most recent data related to the effects of neuropeptides on noninflammatory fat tissue components are described. In addition, a discussion to associate neuropeptide-induced, adipose tissue-mediated responses with the generation of intestinal inflammatory conditions such as Crohn's disease is included.
Collapse
Affiliation(s)
- Iordanes Karagiannides
- Inflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-7019, USA
| | | |
Collapse
|
9
|
Murano I, Barbatelli G, Giordano A, Cinti S. Noradrenergic parenchymal nerve fiber branching after cold acclimatisation correlates with brown adipocyte density in mouse adipose organ. J Anat 2008; 214:171-8. [PMID: 19018882 DOI: 10.1111/j.1469-7580.2008.01001.x] [Citation(s) in RCA: 144] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023] Open
Abstract
The mammalian adipose organ is composed of subcutaneous and visceral depots containing white and brown adipocytes. Cold acclimatisation induces an increase in the brown component without affecting the overall number of adipocytes; this form of plasticity is associated to obesity and diabetes resistance in experimental models. Cold activates the drive of the sympathetic nervous system to the adipose organ, where the vast majority of nerve fibers are in fact noradrenergic. However, it is unclear whether and how such fibers are involved in the plastic changes of the adipose organ. We thus conducted a systematic study of the distribution and number of sympathetic noradrenergic nerve fibers in the adipose organ of mice kept at different environmental temperatures. Adult Sv129 female mice were kept at 28 degrees C or 6 degrees C for 10 days. The density of tyrosine hydroxylase (noradrenergic)-positive nerve fibers (no. of fibers per 100 adipocytes) was calculated in the subcutaneous and visceral depots of the adipose organ, and a correlation was sought between fiber density and proportion of brown adipocytes. Tyrosine hydroxylase-positive parenchymal fibers were detected in all subcutaneous and visceral depots among white as well as brown adipocytes, the mediastinal depot displaying the densest innervation. Cold acclimatisation induced a threefold increase in the total number of TH fibers in the whole organ. The proportion of brown adipocytes positively correlated with noradrenergic fiber density in the organ. Taken together, these data suggest that cold acclimatisation induces noradrenergic fiber branching in the adipose organ of adult mice, and that such changes may be a precondition for its plastic transformation into a brown phenotype.
Collapse
Affiliation(s)
- I Murano
- Institute of Normal Human Morphology, University of Ancona (Politecnica delle Marche), Ancona, Italy
| | | | | | | |
Collapse
|
10
|
Oort PJ, Knotts TA, Grino M, Naour N, Bastard JP, Clément K, Ninkina N, Buchman VL, Permana PA, Luo X, Pan G, Dunn TN, Adams SH. Gamma-synuclein is an adipocyte-neuron gene coordinately expressed with leptin and increased in human obesity. J Nutr 2008; 138:841-8. [PMID: 18424589 PMCID: PMC3160639 DOI: 10.1093/jn/138.5.841] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2007] [Revised: 01/08/2008] [Accepted: 02/09/2008] [Indexed: 01/19/2023] Open
Abstract
Recently, we characterized tumor suppressor candidate 5 (Tusc5) as an adipocyte-neuron PPARgamma target gene. Our objective herein was to identify additional genes that display distinctly high expression in fat and neurons, because such a pattern could signal previously uncharacterized functional pathways shared in these disparate tissues. gamma-Synuclein, a marker of peripheral and select central nervous system neurons, was strongly expressed in white adipose tissue (WAT) and peripheral nervous system ganglia using bioinformatics and quantitative PCR approaches. Gamma-synuclein expression was determined during adipogenesis and in subcutaneous (SC) and visceral adipose tissue (VAT) from obese and nonobese humans. Gamma-synuclein mRNA increased from trace levels in preadipocytes to high levels in mature 3T3-L1 adipocytes and decreased approximately 50% following treatment with the PPARgamma agonist GW1929 (P < 0.01). Because gamma-synuclein limits growth arrest and is implicated in cancer progression in nonadipocytes, we suspected that expression would be increased in situations where WAT plasticity/adipocyte turnover are engaged. Consistent with this postulate, human WAT gamma-synuclein mRNA levels consistently increased in obesity and were higher in SC than in VAT; i.e. they increased approximately 1.7-fold in obese Pima Indian adipocytes (P = 0.003) and approximately 2-fold in SC and VAT of other obese cohorts relative to nonobese subjects. Expression correlated with leptin transcript levels in human SC and VAT (r = 0.887; P < 0.0001; n = 44). Gamma-synuclein protein was observed in rodent and human WAT but not in negative control liver. These results are consistent with the hypothesis that gamma-synuclein plays an important role in adipocyte physiology.
Collapse
Affiliation(s)
- Pieter J. Oort
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Trina A. Knotts
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Michel Grino
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Nadia Naour
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Jean-Phillipe Bastard
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Karine Clément
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Natalia Ninkina
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Vladimir L. Buchman
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Paska A. Permana
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Xunyi Luo
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Guohua Pan
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Tamara N. Dunn
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| | - Sean H. Adams
- USDA/Agricultural Research Service Western Human Nutrition Research Center, Davis, CA 95616; Institute National de la Santé et de la Recherche Médicale U626, Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex, France; Assistance Publique/Hopitaux de Paris, Pitié-Saltéprière and Tenon Hospitals, 75013 Paris, France University Pierre and Marie Curie, 75006 Paris, France; Institute National de la Santé et de la Recherche Médicale U872, Cordelier Research Center, 75006 Paris, France; School of Biosciences, Cardiff University, Cardiff CF10 3US UK; Carl T. Hayden Veterans Affairs Medical Center, Phoenix, AZ 85012; Campbell Family Institute for Breast Cancer Research, Toronto M5G 1L7 Canada; and Department of Nutrition, University of California, Davis, CA 95616
| |
Collapse
|
11
|
Abstract
The preponderance of basic obesity research focuses on its development as affected by diet and other environmental factors, genetics and their interactions. By contrast, we have been studying the reversal of a naturally-occurring seasonal obesity in Siberian hamsters. In the course of this work, we determined that the sympathetic innervation of white adipose tissue (WAT) is the principal initiator of lipid mobilization not only in these animals, but in all mammals including humans. We present irrefutable evidence for the sympathetic nervous system (SNS) innervation of WAT with respect to neuroanatomy (including its central origins as revealed by transneuronal viral tract tracers), neurochemistry (norepinephrine turnover studies) and function (surgical and chemical denervation). A relatively unappreciated role of WAT SNS innervation also is reviewed--the control of fat cell proliferation as shown by selective chemical denervation that triggers adipocyte proliferation, although the precise mechanism by which this occurs presently is unknown. There is no, however, equally strong evidence for the parasympathetic innervation of this tissue; indeed, the data largely are negative severely questioning its existence and importance. Convincing evidence also is given for the sensory innervation of WAT (as shown by tract tracing and by markers for sensory nerves in WAT), with suggestive data supporting a possible role in conveying information on the degree of adiposity to the brain. Collectively, these data offer an additional or alternative view to the predominate one of the control of body fat stores via circulating factors that serve as efferent and afferent communicators.
Collapse
Affiliation(s)
- Timothy J Bartness
- Department of Biology, Neurobiology and Behavior Program, Georgia State University, Atlanta, GA 30302-4010, USA.
| | | |
Collapse
|